Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    23982366 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
GS-7977 With Ribavirin for Hepatitis C (SPARE)
Condition: Hepatitis C
Interventions: Drug: GS7977;   Drug: RBV
2 Withdrawn A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV CDC Category A1
Intervention: Drug: Sofosbuvir + Simeprevir

Indicates status has not been verified in more than two years